Xigris (drotrecogin alfa) was a recombinant human activated protein C indicated for severe sepsis. Note: It was withdrawn worldwide in 2011 after the PROWESS-SHOCK trial showed no mortality benefit. Glucagon is for hypoglycemia, Forteo is for osteoporosis, and Strattera is for ADHD.